In vitro evidence for the involvement of H2S pathway in the effect of clodronate during inflammatory response
Abstract Clodronate is a bisphosphonate agent commonly used as anti-osteoporotic drug. Throughout its use, additional anti-inflammatory and analgesic properties have been reported, although the benefits described in the literature could not solely relate to their inhibition of bone resorption. Thus,...
Guardado en:
Autores principales: | Rosangela Montanaro, Alessio D’Addona, Andrea Izzo, Carlo Ruosi, Vincenzo Brancaleone |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9d63c65bd58c4f1e8a98992d463f86f9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Emergent synthetic approach for management of complexity in production systems
por: D.M. D’Addona
Publicado: (2019) -
TIME-KILL ASSAY: AN EFFICACY OF SYNERGY BETWEEN CARBAPENEMS AND CLODRONIC ACID
por: A. G. Afinogenova, et al.
Publicado: (2018) -
Clodronate, an inhibitor of the vesicular nucleotide transporter, ameliorates steatohepatitis and acute liver injury
por: Nao Hasuzawa, et al.
Publicado: (2021) -
Use of clodronate liposomes to deplete phagocytic immune cells in Drosophila melanogaster and Aedes aegypti
por: Jyothsna Ramesh Kumar, et al. -
Using patient-derived iPSCs to develop humanized mouse models for chronic myelomonocytic leukemia and therapeutic drug identification, including liposomal clodronate
por: Kazuki Taoka, et al.
Publicado: (2018)